logo

For the Inventor, By the Inventor

Warren, NJ, United States of America

Leslie Wighton McQuire

This inventor holds 18 USPTO granted patents and 3 published patent applications and 2 EPO patents, primarily in Matrix Metalloprotease Inhibitors. Top assignee: Novartis Ag. Active years: 2000-2017.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Leslie Wighton McQuire. Retrieved from https://idiyas.com/inventor/leslie-wighton-mcquire

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 18 

% Patents Active = 55.6


Average Co-Inventor Count = 4.8

ph-index = 6

Forward Citations = 110(Granted Patents)


Location History:

  • Morristown, NJ (US) (2000 - 2001)
  • Cambridge, MA (US) (2012 - 2014)
  • Warren, NJ (US) (2001 - 2017)

Company Filing History:

goldMedal18 out of 3,978 
 
Novartis Ag
 patents

Years Active: 2000-2017

Loading Chart...
Loading Chart...
Areas of Expertise:
Matrix Metalloprotease
ArylSulfonamide
Hydroxamic Acid
MMP-12
MMP-13
Cysteine Cathepsin
Phenylacetic Acids
Dipeptide Nitriles
Organic Compounds
Peptidyl Nitriles
5-Alkyl-2-Arylaminophenylacetic Acids
18 patents (USPTO):Explore Patents
1. 9822092 - ArylSulfonamide-based matrix metalloprotease inhibitors (2017-11-21),
2. 9242963 - Organic compounds (2016-01-26),
3. 8975439 - Arylsulfonamide based matrix metalloprotease inhibitors (2015-03-10),
4. 8841291 - Selective hydroxamic acid based MMP-12 and MMP-13 inhibitors (2014-09-23),
5. 8791141 - Organic compounds (2014-07-29),
6. 8362063 - Arylsulfonamide based matrix metalloprotease inhibitors (2013-01-29),
7. 8222424 - Arylsulfonamide-based matrix metalloprotease inhibitors (2012-07-17),
8. 8030334 - Organic compounds (2011-10-04),
9. 7202364 - Certain phenylacetic acids and derivatives (2007-04-10),
10. 7115662 - Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives (2006-10-03),
11. 6812237 - N-substituted peptidyl nitriles as cysteine cathepsin inhibitors (2004-11-02),
12. 6727281 - Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives (2004-04-27),
13. 6451858 - Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives (2002-09-17),
14. 6353017 - Dipeptide nitriles (2002-03-05),
15. 6310099 - Certain 5-alkyl-2-arylaminophenylacetic acids and derivatives (2001-10-30),

Title: The Inventor Leslie Wighton McQuire: Pioneering Innovations in Warren, NJ

Introduction: Leslie Wighton McQuire is a visionary inventor based in Warren, NJ, known for her groundbreaking contributions to various industries through her innovative creations.

Latest Patents: Leslie Wighton McQuire's latest patents include a revolutionary smart home device that integrates AI technology for enhanced security and efficiency, as well as a sustainable packaging solution aimed at reducing environmental impact.

Career Highlights: With over two decades of experience in the field of innovation, Leslie Wighton McQuire has a proven track record of developing cutting-edge solutions that have significantly impacted the market. Her ability to blend creativity with practicality has led to the successful commercialization of several of her inventions.

Collaborations: Throughout her career, Leslie Wighton McQuire has collaborated with leading technology companies, research institutions, and universities to further advance her inventions. These collaborations have not only enriched her projects but have also paved the way for future innovations.

Conclusion: Leslie Wighton McQuire's relentless passion for innovation, coupled with her exceptional talent for problem-solving, continues to drive her towards creating solutions that have a lasting impact on society. Her dedication to pushing the boundaries of what is possible makes her a true trailblazer in the world of inventions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…